PG
VHT icon

Prostatis Group’s Vanguard Health Care ETF VHT Stock Holding History

Prostatis Group’s Portfolio VHT Stock Details VHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$324K Sell
1,189
-403
-25% -$115K 0.08% 134
2025
Q4 		$458K Sell
1,592
-270
-15% -$75.4K 0.11% 108
2025
Q3 		$483K Buy
1,862
+6
+0.3% +$1.5K 0.12% 97
2025
Q2 		$461K Buy
1,856
+129
+7% +$31.9K 0.13% 100
2025
Q1 		$457K Buy
1,727
+24
+1% +$6.39K 0.14% 96
2024
Q4 		$432K Sell
1,703
-365
-18% -$98.3K 0.13% 110
2024
Q3 		$584K Buy
2,068
+232
+13% +$64.4K 0.19% 86
2024
Q2 		$488K Sell
1,836
-373
-17% -$97.8K 0.17% 97
2024
Q1 		$598K Buy
2,209
+220
+11% +$57.8K 0.23% 86
2023
Q4 		$499K Buy
1,989
+596
+43% +$141K 0.21% 84
2023
Q3 		$327K Sell
1,393
-292,253
-100% -$71.2M 0.16% 78
2023
Q2 		$311K Buy
293,646
+292,340
+22,384% +$71.1M 0.14% 88
2023
Q1 		$312K Buy
1,306
+1
+0.1% +$241 0.16% 79
2022
Q4 		$324K Buy
1,305
+1
+0.1% +$242 0.2% 75
2022
Q3 		$292K Buy
+1,304
New +$311K 0.34% 44

Other funds holding VHT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCH
PGIM Custom Harvest Newark, New Jersey $6.4B AUM 18.53% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Prostatis Group's VHT Position: Q1 2026 in Review

Prostatis Group reduced its Vanguard Health Care ETF (VHT) stake by 25% in Q1 2026, selling an estimated $115K and leaving 1,189 shares worth $324K. The position accounts for 0.08% of the portfolio, ranked #134.

Prostatis Group first reported a position in VHT in Q3 2022 and has held it in 15 quarters since. The position peaked at $598K in Q1 2024. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • Prostatis Group held 1,189 shares of Vanguard Health Care ETF worth $324K as of Q1 2026.
  • Prostatis Group sold 403 Vanguard Health Care ETF shares in Q1 2026, an estimated $115K.
  • Vanguard Health Care ETF made up 0.08% of Prostatis Group's portfolio in Q1 2026, its #134 holding.
  • Prostatis Group first reported a position in Vanguard Health Care ETF in Q3 2022 and has held it in 15 quarters since.
  • Prostatis Group's Vanguard Health Care ETF position peaked at $598K in Q1 2024.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.